1、S-1/A 1 tm2514537d3_s1a.htm S-1/A As filed with the U.S.Securities and Exchange Commission on June 5,2025.UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549 FORM S-1/A(Amendment No.1)REGISTRATION STATEMENTUNDER THE SECURITIES ACT OF 1933 ENTERO THERAPEUTICS,INC.(Exact name of regist

2、rant as specified in its charter)Delaware 2834 46-4993860(State or other jurisdiction ofincorporation or organization)(Primary Standard IndustrialClassification Code Number)(I.R.S.EmployerIdentification No.)777 Yamato Road,Suite 502Boca Raton,Florida 33431(561)589-7020(Address,including zip code,and

3、 telephone number,including area code,of registrants principal executive offices)Richard PaoloneInterim Chief Executive Officer777 Yamato Road,Suite 502Boca Raton,Florida 33431(561)589-7020(Name,address,including zip code,and telephone number,including area code,of agent for service)Copies to:Ross C

4、armel,Esq.Avital Perlman,Esq.Sichenzia Ross Ference Carmel LLP1185 Avenue of the Americas,31st FloorNew York,New York 10036(212)930-9700 Joseph M.Lucosky,Esq.Steven Lipstein,Esq.Lucosky Brookman LLP101 Wood Avenue South,5th FloorWoodbridge,New Jersey 08830(732)395-4400 As soon as practicable after t

5、he effective date of this registration statement(Approximate date of commencement of proposed sale to the public)If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant toRule 415 under the Securities Act of 1933 check the following box.x If

6、 this Form is filed to register additional securities for an offering pursuant to Rule 462(b)under the Securities Act,checkthe following box and list the Securities Act registration statement number of the earlier effective registration statement for thesame offering.If this Form is a post-effective